Methods of determining a chemotherapeutic regimen based on loss of heterozygosity at the thymidylate synthase locus

Details for Australian Patent Application No. 2004216231 (hide)

Owner Response Genetics, Inc.

Inventors Danenberg, Kathleen D.

Agent Shelston IP

Pub. Number AU-B-2004216231

PCT Pub. Number WO2004/075833

Priority 10/373,752 27.02.03 US

Filing date 20 February 2004

Wipo publication date 10 September 2004

Acceptance publication date 23 July 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/075833 Priority application(s): WO2004/075833

23 July 2009 Application Accepted

  Published as AU-B-2004216231

19 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004216235-4-((2,4-Dichloro-5-methoxyphenyl)amin o)-6-alkoxy-3-quinolinecarbonitriles for the treatment of ischemic injury

2004216229-System and method for measuring cross-sectional areas and pressure gradients in luminal organs